Researchers present novel capsule-mediated gastrointestinal mRNA delivery approach Feb. 8, 2022 No Comments
eTheRNA and Merck KGaA sign research agreement to assess mRNA technology for therapeutic vaccination Feb. 7, 2022 No Comments
Engineered virus-like particles for in vivo delivery of gene editing proteins Jan. 24, 2022 No Comments
4basebio and eTheRNA collaborate to evaluate linear DNA for mRNA production Jan. 18, 2022 No Comments
Amgen and Arrakis collaborate to discover and develop targeted RNA degrader therapeutics Jan. 12, 2022 No Comments
Pfizer and Codex DNA collaborate to leverage EDS technology for mRNA-based vaccines Jan. 11, 2022 No Comments